Clinical and Molecular Hepatology (Clin Mol Hepatol, CMH)

Kyoung-Bun Lee

Clin Mol Hepatol. 2016;22(3):400-405. Published online September 25, 2016

DOI: https://doi.org/10.3350/cmh.2016.0105

View: 11724 Download: 310 Web of Science: 13 Crossref: 12

Se Kyung Park, Young Seok Kim, Sang Gyune Kim, Jae Young Jang, Jong Ho Moon, Moon Sung Lee, Boo Sung Kim, Eun Suk Koh, Jung Mi Park

Clin Mol Hepatol. 2010;16(3):325-328. Published online September 30, 2010

DOI: https://doi.org/10.3350/kjhep.2010.16.3.325

View: 6261 Download: 44 Crossref: 11

Yoon Mi Jeen , So Young Jin

Clin Mol Hepatol. 2009;15(4):524-527. Published online December 31, 2009

DOI: https://doi.org/10.3350/kjhep.2009.15.4.524

View: 4318 Download: 37 Crossref: 1

1 |

Viewed By 5314	Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Viewed By 5255	MAFLD: How is it different from NAFLD?
Viewed By 5157	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Viewed By 3871	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Viewed By 3808	Global incidence and prevalence of nonalcoholic fatty liver disease

Cited By 114	Assessing the performance of ChatGPT in answering questions regarding cirrhosis and hepatocellular carcinoma
Cited By 103	2022 KLCA-NCC Korea practice guidelines for the management of hepatocellular carcinoma
Cited By 76	Global incidence and prevalence of nonalcoholic fatty liver disease
Cited By 65	Forecasted 2040 global prevalence of nonalcoholic fatty liver disease using hierarchical bayesian approach
Cited By 52	MAFLD: How is it different from NAFLD?

Search